{"success":true,"data":{"pressRelease":{"id":"131212","rtpr_id":"nGNX8WBLG","ticker":"AARD","exchange":"NASDAQ","all_tickers":["AARD","FTK","GDDY","SMPL"],"title":"Important Notice to Long-Term Shareholders Aardvark Therapeutics, Inc. (NASDAQ: AARD); Flotek Industries, Inc. (NYSE: FTK); GoDaddy Inc. (NYSE: GDDY); and The Simply Good Foods Company (NASDAQ: SMPL); Grabar Law Office is Investigating Claims on Your Behalf","author":"Globe Newswire","published_at":"2026-08-31T12:44:25.139Z","article_body":"PHILADELPHIA, Aug. 31, 2026 (GLOBE NEWSWIRE) --\n\nAardvark Therapeutics, Inc. (NASDAQ: AARD):\n\nGrabar Law Office is investigating claims on behalf of Aardvark Therapeutics,\nInc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the\nCompany’s February 13, 2025, initial public offering (IPO) and have\ncontinued to hold their shares.\n\nWhat is This Investigation About? The investigation follows the filing of a\nsecurities class action against Aardvark and certain of its officers and\ndirectors alleging violations of the federal securities laws in connection\nwith statements concerning the safety and prospects of the Company’s lead\ndrug candidate, ARD-101.\n\nIf you purchased Aardvark Therapeutics, Inc. (NASDAQ: AARD) shares on or\nshortly after the Company’s February 13, 2025 IPO, and still hold shares\ntoday, you can seek corporate reforms, the return of funds back to the\ncompany, and a court approved incentive award at no cost to you whatsoever\nthrough a shareholder governance action. You are encouraged to visit\nhttps://grabarlaw.com/the-latest/aardvark-shareholder-investigation/, contact\nJoshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085 to learn more.\n\nWhat is Alleged? Aardvark (NASDAQ: AARD) completed its IPO on or about\nFebruary 13, 2025. The Company sold approximately 5.9 million shares at $16.00\nper share, generating approximately $87.6 million in net proceeds after\nunderwriting discounts and commissions.\n\nAccording to the recently filed securities complaint, Aardvark’s offering\ndocuments represented that ARD-101 had been “well-tolerated” in earlier\nclinical trials, had limited systemic absorption, and had demonstrated no\nserious adverse events. The complaint alleges that the offering documents were\nmaterially false or misleading because they failed to disclose that ARD-101\nwas allegedly less safe than investors had been led to believe and that its\nclinical, regulatory, and commercial prospects were therefore overstated.\n\nThe complaint further alleges that similar representations concerning\nARD-101’s safety continued after the IPO. For example, Company\nrepresentatives subsequently described ARD-101 as having a “very, very\nclean” safety profile and represented that its limited systemic exposure\nreduced the likelihood of side effects.\n\nOn February 27, 2026, Aardvark announced that it was voluntarily pausing\nenrollment and dosing in the Phase 3 HERO trial after identifying reversible\ncardiac observations during safety monitoring in a healthy-volunteer study.\nFollowing the announcement, Aardvark’s stock price allegedly declined\napproximately 56%, closing at $5.47 per share on March 2, 2026.\n\nThen, on May 14, 2026, Aardvark announced that the FDA had placed a full\nclinical hold on the investigational new drug application for ARD-101,\nincluding the Phase 3 HERO trial and its open-label extension. According to\nthe complaint, Aardvark’s stock declined another 32.1% the following day,\nclosing at $4.57 per share.\n\nWhat Can You Do Now? If you purchased Aardvark shares at or shortly after the\nFebruary 13, 2025 IPO, and continue to own those shares, you may have\nimportant rights concerning the Company’s management. You can seek corporate\nreforms, the return of funds back to the company, and a court approved\nincentive award at no cost to you whatsoever through a shareholder governance\naction. Please visit\nhttps://grabarlaw.com/the-latest/aardvark-shareholder-investigation/, contact\nJoshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085 to learn\nmore.   #AARD $AARD #Aardvark\n\nFlotek Industries, Inc. (NYSE: FTK):\n\nGrabar Law Office is investigating potential claims on behalf of shareholders\nof Flotek Industries, Inc. (NYSE: FTK).\n\nWhat is This Investigation About? The investigation concerns possible breaches\nof fiduciary duty and other corporate governance issues relating to the\nCompany's recently terminated Puerto Rico Electric Power Authority (\"PREPA\")\nproject.\n\nIf you have continuously owned Flotek Industries, Inc. (NYSE: FTK) shares\nsince before August 3, 2026, you may be able to pursue corporate reforms, the\nreturn of funds back to the company, and a court approved incentive award at\nno cost to you whatsoever. please Visit\nhttps://grabarlaw.com/the-latest/flotek-shareholder-investigation/, contact\nJoshua H. Grabar at jgrabar@grabarlaw.com, or call 267-507-6085 to learn more.\nAlternatively, if you purchased shares between August 3, 2026, and August 17,\n2026, you can participate in the class action.\n\nWhat is Alleged? On August 26, 2026, a federal securities fraud class action\nwas filed against Flotek (NYSE: FTK) and certain of its senior officers. The\ncomplaint alleges that Flotek made materially false and/or misleading\nstatements and failed to disclose material information concerning a 10-year\nagreement associated with a 400-megawatt natural gas-fired power generation\nproject for PREPA.\n\nAccording to the complaint, Flotek announced on August 3, 2026, that it had\nentered into a 10-year agreement to support the PREPA project and expected the\narrangement to generate approximately $400 million in potential revenue\nbacklog. Flotek subsequently highlighted the contract in its quarterly\nfinancial results, investor materials and Form 10-Q.\n\nThe underlying class action complaint alleges, however, that there were\nsignificant questions concerning the experience, organization and financial\ncapacity of certain members of the consortium responsible for the underlying\nPREPA project. The complaint further recounts allegations that Enchanted Rock,\nLLC—an entity whose participation allegedly had been relied upon in\nevaluating the project—later stated that it was not participating in the\nproject and that its name and signature had been used without authorization.\n\nAccording to Flotek's subsequent public disclosures, the Financial Oversight\nand Management Board for Puerto Rico ultimately revoked its approval of the\nunderlying power-generation contract and directed PREPA to terminate it.\nFlotek further disclosed that certain allegations concerning the procurement\nprocess had been referred to the Puerto Rico Department of Justice and\ncorresponding federal authorities.\n\nOn August 19, 2026, Flotek announced that PREPA had formally terminated the\nunderlying Power Purchase and Operating Agreement, effective immediately.\nAccording to Flotek, PREPA identified two independent grounds for termination:\nthe consortium's failure to provide required performance security within the\ncontractual timeframe and the Oversight Board's revocation of its approval.\n\nWhat is Grabar Law Office's Investigation About? Grabar Law Office is\ninvestigating whether Flotek's directors and officers adequately discharged\ntheir fiduciary duties in connection with these events, including whether:\nappropriate due diligence was performed before Flotek assumed significant\nresponsibilities in the PREPA project; Company leadership adequately\ninvestigated or responded to potential warning signs concerning the project's\nconsortium participants; material information concerning the project was\ntimely escalated to Flotek's Board of Directors; Flotek maintained adequate\ninternal controls, disclosure controls and risk-management procedures\nconcerning significant new contractual commitments; the Board appropriately\noversaw Flotek's expansion into infrastructure-scale power-generation\nservices, an area the Company itself described as an emerging line of business\nwith limited operating history; and Flotek suffered harm as a result of any\nfailures of oversight, disclosure, internal controls or corporate governance.\n\nWhat Can Flotek Shareholders Do Now? If you have continuously owned Flotek\nIndustries, Inc. (NYSE: FTK) shares since before August 3, 2026, please visit\nhttps://grabarlaw.com/the-latest/flotek-shareholder-investigation/, contact\nJoshua H. Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can\npursue corporate reforms, the return of funds back to the company, and a court\napproved incentive award at no cost to you whatsoever.   Alternatively, if\nyou purchased shares between August 3, 2026, and August 17, 2026, you can\nparticipate in the class action. #Flotek #FTK $FTK\n\nGoDaddy Inc. (NYSE: GDDY):\n\nGrabar Law Office is investigating claims on behalf of shareholders of GoDaddy\nInc. (NYSE: GDDY).\n\nWhat is This Investigation About? concerning possible breaches of fiduciary\nduty and other corporate governance issues involving certain officers and\ndirectors of the Company. The investigation follows the filing of a federal\nsecurities class action, Johnson v. GoDaddy Inc., et al., No. 26-cv-7144\n(S.D.N.Y.), against GoDaddy, Chief Executive Officer Aman Bhutani, and Chief\nFinancial Officer Mark McCaffrey.\n\nCurrent GoDaddy Inc. (NYSE: GDDY) shareholders who have held shares since\nbefore September 3, 2025, can seek corporate reforms, the return of funds back\nto the company, and a court approved incentive award at no cost to them\nwhatsoever. Visit\nhttps://grabarlaw.com/the-latest/godaddy-shareholder-investigation/, contact\nJoshua H. Grabar at jgrabar@grabarlaw.com, or call 267-507-6085 to learn more.\n\nWhat is Alleged? According to the complaint, GoDaddy Inc. (NYSE: GDDY), via\ncertain of its officers, repeatedly told investors that its strategy was\nfocused on attracting “high-intent” customers and had moved away from\ndiscounting at the front end of its customer funnel. The complaint alleges,\nhowever, that during the same period the Company had implemented a heavily\ndiscounted promotional price for one-year .com domain contracts, which\nallegedly resulted in shorter-term contracts, lower average order values, and\ndeceleration in total bookings growth.\n\nThe complaint further alleges that GoDaddy continued to represent that its\nhigh-intent customer strategy was working and that average order size was\nincreasing, while allegedly failing to disclose the impact that the one-year\npromotional program was having on bookings.\n\nOn February 24, 2026, GoDaddy reported its fourth-quarter and full-year 2025\nresults and disclosed that fourth-quarter total bookings growth had\ndecelerated to 5%, down from 9% in the prior quarter and below analyst\nexpectations. During the associated earnings call, the Company disclosed that\nit had introduced promotional pricing for one-year .com domains and that the\nshift in contract term and promotional pricing had reduced upfront bookings\nand near-term revenue.\n\nFollowing these disclosures, GoDaddy’s stock price declined from $92.30 per\nshare on February 24, 2026 to $79.12 per share on February 25, 2026, a drop of\nmore than 14%. The accompanying release similarly states that the challenged\npromotional strategy allegedly contributed to weaker bookings and that\nGoDaddy’s shares fell more than 14% after the disclosures.\n\nWhat is Grabar Law Office’s Investigation About? Grabar Law Office is\ninvestigating whether certain GoDaddy officers and directors may have breached\nfiduciary duties owed to the Company or otherwise failed to adequately oversee\nGoDaddy’s business strategy, public disclosures, financial reporting, and\nrisk-management processes.\n\nAmong other things, the investigation concerns whether: Company leadership\nadequately disclosed the nature and impact of GoDaddy’s promotional\ndiscounting strategy; the Board and senior management maintained appropriate\noversight over material changes to GoDaddy’s go-to-market strategy;\nGoDaddy’s disclosure controls were sufficient to ensure that investors\nreceived accurate and complete information concerning bookings trends and\ncustomer-acquisition practices; certain officers or directors permitted or\ncaused the Company to make materially misleading public statements; and the\nCompany has suffered or may suffer harm through securities litigation, related\nlegal expenses, reputational damage, or other corporate losses.\n\nWhat Can You Do Now? If you are a current GoDaddy Inc. (NYSE: GDDY)\nshareholder and have held shares since before September 3, 2025, you can seek\ncorporate reforms, the return of funds back to the company, and a court\napproved incentive award at no cost to you whatsoever. Visit\nhttps://grabarlaw.com/the-latest/godaddy-shareholder-investigation/, contact\nJoshua H. Grabar at jgrabar@grabarlaw.com, or call 267-507-6085 to learn more.\n$GDDY #GDDY #Godaddy\n\nThe Simply Good Foods Company (NASDAQ: SMPL):\n\nGrabar Law Office is investigating claims on behalf of shareholders of The\nSimply Good Foods Company (NASDAQ: SMPL).\n\nWhat is This Investigation About? The investigation concerns whether certain\nofficers and directors breached the fiduciary duties they owed to the company.\n\nIf you purchased The Simply Good Foods Company (NASDAQ: SMPL) shares before\nFebruary 24, 2024, and still hold shares today, you can seek corporate\nreforms, the return of funds back to the company, and a court approved\nincentive award at no cost to you whatsoever. You are encouraged to visit\nhttps://grabarlaw.com/the-latest/smpl-shareholder-investigation/, contact\nJoshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085 to learn more.\n\nWhat is Alleged? As alleged in a recently filed securities fraud class action\nComplaint, The Simply Good Foods Company (NASDAQ: SMPL), through certain of\nits officers, made materially false and misleading statements and/or failed to\ndisclose materially adverse facts pertaining to the Company’s business,\noperations, and prospects. Specifically, Defendants failed to disclose to\ninvestors that: (1) that Simply Good Foods had lost key managerial personnel\nfollowing the acquisition of OWYN necessary for the successful integration of\nthe acquired OWYN assets; (2) that Simply Good Foods had materially increased\nits general and administrative spending to compensate for the loss of key\nmanagerial personnel; (3) the addition of a new pea protein supplier for OWYN\nprior to the acquisition had created significant product quality issues which\nhad negatively impacted the product; (4) Simply Good Foods had engaged in\npromotional activities for OWYN products above its historical practices,\neroding margins; (5) that, in order to stem the margin erosion, Simply Good\nFoods had cut brand support and marketing, further depressing product sales;\n(6) as a result of the above, the OWYN acquisition had largely failed to\nachieve its key strategic goals, the integration of OWYN had run into severe\noperational and execution problems, and the business and operational results\nfor the OWYN segment had been materially negatively impacted, undermining the\nacquisitions economic rationale; and (7) that, as a result of the foregoing,\nDefendants’ positive statements about the Company’s business, operations,\nand prospects were materially misleading and/or lacked a reasonable basis.\n\nWhat Can You Do Now? If you purchased The Simply Good Foods Company (NASDAQ:\nSMPL) shares before February 24, 2024, and still hold shares today, please\nvisit https://grabarlaw.com/the-latest/smpl-shareholder-investigation/,\ncontact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can\nseek corporate reforms, the return of funds back to the company, and a court\napproved incentive award at no cost to you whatsoever. #SMPL #SimplyGoodFoods\n$SMPL\n\nAttorney Advertising Disclaimer\n(https://www.globenewswire.com/Tracker?data=qMAsZfI9_PXGtQ40PFkFQf3yEZ7vPxepb63KbXHI9fzdhIQ1GfOquWkQhoYnreLExEaiVwxANz2aMqbfT_vJsCwF0CRc07Im2YFj71Z9sLY753_Zsc16RWEGu8bPdJIX2n6jGU7WLqU9fdMDZv2fD4aQ6ytPgMSrJPHJB7a7nzQ=)\n\nContact:\nJoshua H. Grabar, Esq.\nGrabar Law Office\nOne Liberty Place\n1650 Market Street, Suite 3600\nPhiladelphia, PA 19103\nTel:  267-507-6085\nEmail: jgrabar@grabarlaw.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/6c801a52-ae63-4c0d-a62c-5713903ad05d)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNX8WBLG","title":"Important Notice to Long-Term Shareholders Aardvark Therapeutics, Inc. (NASDAQ: AARD); Flotek Industries, Inc. (NYSE: FTK); GoDaddy Inc. (NYSE: GDDY); and The Simply Good Foods Company (NASDAQ: SMPL); Grabar Law Office is Investigating Claims on Your Behalf","author":"Globe Newswire","ticker":"AARD","created":"2026-08-31T12:44:25.139Z","tickers":["AARD","FTK","GDDY","SMPL"],"exchange":"NASDAQ","article_body":"PHILADELPHIA, Aug. 31, 2026 (GLOBE NEWSWIRE) --\n\nAardvark Therapeutics, Inc. (NASDAQ: AARD):\n\nGrabar Law Office is investigating claims on behalf of Aardvark Therapeutics,\nInc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the\nCompany’s February 13, 2025, initial public offering (IPO) and have\ncontinued to hold their shares.\n\nWhat is This Investigation About? The investigation follows the filing of a\nsecurities class action against Aardvark and certain of its officers and\ndirectors alleging violations of the federal securities laws in connection\nwith statements concerning the safety and prospects of the Company’s lead\ndrug candidate, ARD-101.\n\nIf you purchased Aardvark Therapeutics, Inc. (NASDAQ: AARD) shares on or\nshortly after the Company’s February 13, 2025 IPO, and still hold shares\ntoday, you can seek corporate reforms, the return of funds back to the\ncompany, and a court approved incentive award at no cost to you whatsoever\nthrough a shareholder governance action. You are encouraged to visit\nhttps://grabarlaw.com/the-latest/aardvark-shareholder-investigation/, contact\nJoshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085 to learn more.\n\nWhat is Alleged? Aardvark (NASDAQ: AARD) completed its IPO on or about\nFebruary 13, 2025. The Company sold approximately 5.9 million shares at $16.00\nper share, generating approximately $87.6 million in net proceeds after\nunderwriting discounts and commissions.\n\nAccording to the recently filed securities complaint, Aardvark’s offering\ndocuments represented that ARD-101 had been “well-tolerated” in earlier\nclinical trials, had limited systemic absorption, and had demonstrated no\nserious adverse events. The complaint alleges that the offering documents were\nmaterially false or misleading because they failed to disclose that ARD-101\nwas allegedly less safe than investors had been led to believe and that its\nclinical, regulatory, and commercial prospects were therefore overstated.\n\nThe complaint further alleges that similar representations concerning\nARD-101’s safety continued after the IPO. For example, Company\nrepresentatives subsequently described ARD-101 as having a “very, very\nclean” safety profile and represented that its limited systemic exposure\nreduced the likelihood of side effects.\n\nOn February 27, 2026, Aardvark announced that it was voluntarily pausing\nenrollment and dosing in the Phase 3 HERO trial after identifying reversible\ncardiac observations during safety monitoring in a healthy-volunteer study.\nFollowing the announcement, Aardvark’s stock price allegedly declined\napproximately 56%, closing at $5.47 per share on March 2, 2026.\n\nThen, on May 14, 2026, Aardvark announced that the FDA had placed a full\nclinical hold on the investigational new drug application for ARD-101,\nincluding the Phase 3 HERO trial and its open-label extension. According to\nthe complaint, Aardvark’s stock declined another 32.1% the following day,\nclosing at $4.57 per share.\n\nWhat Can You Do Now? If you purchased Aardvark shares at or shortly after the\nFebruary 13, 2025 IPO, and continue to own those shares, you may have\nimportant rights concerning the Company’s management. You can seek corporate\nreforms, the return of funds back to the company, and a court approved\nincentive award at no cost to you whatsoever through a shareholder governance\naction. Please visit\nhttps://grabarlaw.com/the-latest/aardvark-shareholder-investigation/, contact\nJoshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085 to learn\nmore.   #AARD $AARD #Aardvark\n\nFlotek Industries, Inc. (NYSE: FTK):\n\nGrabar Law Office is investigating potential claims on behalf of shareholders\nof Flotek Industries, Inc. (NYSE: FTK).\n\nWhat is This Investigation About? The investigation concerns possible breaches\nof fiduciary duty and other corporate governance issues relating to the\nCompany's recently terminated Puerto Rico Electric Power Authority (\"PREPA\")\nproject.\n\nIf you have continuously owned Flotek Industries, Inc. (NYSE: FTK) shares\nsince before August 3, 2026, you may be able to pursue corporate reforms, the\nreturn of funds back to the company, and a court approved incentive award at\nno cost to you whatsoever. please Visit\nhttps://grabarlaw.com/the-latest/flotek-shareholder-investigation/, contact\nJoshua H. Grabar at jgrabar@grabarlaw.com, or call 267-507-6085 to learn more.\nAlternatively, if you purchased shares between August 3, 2026, and August 17,\n2026, you can participate in the class action.\n\nWhat is Alleged? On August 26, 2026, a federal securities fraud class action\nwas filed against Flotek (NYSE: FTK) and certain of its senior officers. The\ncomplaint alleges that Flotek made materially false and/or misleading\nstatements and failed to disclose material information concerning a 10-year\nagreement associated with a 400-megawatt natural gas-fired power generation\nproject for PREPA.\n\nAccording to the complaint, Flotek announced on August 3, 2026, that it had\nentered into a 10-year agreement to support the PREPA project and expected the\narrangement to generate approximately $400 million in potential revenue\nbacklog. Flotek subsequently highlighted the contract in its quarterly\nfinancial results, investor materials and Form 10-Q.\n\nThe underlying class action complaint alleges, however, that there were\nsignificant questions concerning the experience, organization and financial\ncapacity of certain members of the consortium responsible for the underlying\nPREPA project. The complaint further recounts allegations that Enchanted Rock,\nLLC—an entity whose participation allegedly had been relied upon in\nevaluating the project—later stated that it was not participating in the\nproject and that its name and signature had been used without authorization.\n\nAccording to Flotek's subsequent public disclosures, the Financial Oversight\nand Management Board for Puerto Rico ultimately revoked its approval of the\nunderlying power-generation contract and directed PREPA to terminate it.\nFlotek further disclosed that certain allegations concerning the procurement\nprocess had been referred to the Puerto Rico Department of Justice and\ncorresponding federal authorities.\n\nOn August 19, 2026, Flotek announced that PREPA had formally terminated the\nunderlying Power Purchase and Operating Agreement, effective immediately.\nAccording to Flotek, PREPA identified two independent grounds for termination:\nthe consortium's failure to provide required performance security within the\ncontractual timeframe and the Oversight Board's revocation of its approval.\n\nWhat is Grabar Law Office's Investigation About? Grabar Law Office is\ninvestigating whether Flotek's directors and officers adequately discharged\ntheir fiduciary duties in connection with these events, including whether:\nappropriate due diligence was performed before Flotek assumed significant\nresponsibilities in the PREPA project; Company leadership adequately\ninvestigated or responded to potential warning signs concerning the project's\nconsortium participants; material information concerning the project was\ntimely escalated to Flotek's Board of Directors; Flotek maintained adequate\ninternal controls, disclosure controls and risk-management procedures\nconcerning significant new contractual commitments; the Board appropriately\noversaw Flotek's expansion into infrastructure-scale power-generation\nservices, an area the Company itself described as an emerging line of business\nwith limited operating history; and Flotek suffered harm as a result of any\nfailures of oversight, disclosure, internal controls or corporate governance.\n\nWhat Can Flotek Shareholders Do Now? If you have continuously owned Flotek\nIndustries, Inc. (NYSE: FTK) shares since before August 3, 2026, please visit\nhttps://grabarlaw.com/the-latest/flotek-shareholder-investigation/, contact\nJoshua H. Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can\npursue corporate reforms, the return of funds back to the company, and a court\napproved incentive award at no cost to you whatsoever.   Alternatively, if\nyou purchased shares between August 3, 2026, and August 17, 2026, you can\nparticipate in the class action. #Flotek #FTK $FTK\n\nGoDaddy Inc. (NYSE: GDDY):\n\nGrabar Law Office is investigating claims on behalf of shareholders of GoDaddy\nInc. (NYSE: GDDY).\n\nWhat is This Investigation About? concerning possible breaches of fiduciary\nduty and other corporate governance issues involving certain officers and\ndirectors of the Company. The investigation follows the filing of a federal\nsecurities class action, Johnson v. GoDaddy Inc., et al., No. 26-cv-7144\n(S.D.N.Y.), against GoDaddy, Chief Executive Officer Aman Bhutani, and Chief\nFinancial Officer Mark McCaffrey.\n\nCurrent GoDaddy Inc. (NYSE: GDDY) shareholders who have held shares since\nbefore September 3, 2025, can seek corporate reforms, the return of funds back\nto the company, and a court approved incentive award at no cost to them\nwhatsoever. Visit\nhttps://grabarlaw.com/the-latest/godaddy-shareholder-investigation/, contact\nJoshua H. Grabar at jgrabar@grabarlaw.com, or call 267-507-6085 to learn more.\n\nWhat is Alleged? According to the complaint, GoDaddy Inc. (NYSE: GDDY), via\ncertain of its officers, repeatedly told investors that its strategy was\nfocused on attracting “high-intent” customers and had moved away from\ndiscounting at the front end of its customer funnel. The complaint alleges,\nhowever, that during the same period the Company had implemented a heavily\ndiscounted promotional price for one-year .com domain contracts, which\nallegedly resulted in shorter-term contracts, lower average order values, and\ndeceleration in total bookings growth.\n\nThe complaint further alleges that GoDaddy continued to represent that its\nhigh-intent customer strategy was working and that average order size was\nincreasing, while allegedly failing to disclose the impact that the one-year\npromotional program was having on bookings.\n\nOn February 24, 2026, GoDaddy reported its fourth-quarter and full-year 2025\nresults and disclosed that fourth-quarter total bookings growth had\ndecelerated to 5%, down from 9% in the prior quarter and below analyst\nexpectations. During the associated earnings call, the Company disclosed that\nit had introduced promotional pricing for one-year .com domains and that the\nshift in contract term and promotional pricing had reduced upfront bookings\nand near-term revenue.\n\nFollowing these disclosures, GoDaddy’s stock price declined from $92.30 per\nshare on February 24, 2026 to $79.12 per share on February 25, 2026, a drop of\nmore than 14%. The accompanying release similarly states that the challenged\npromotional strategy allegedly contributed to weaker bookings and that\nGoDaddy’s shares fell more than 14% after the disclosures.\n\nWhat is Grabar Law Office’s Investigation About? Grabar Law Office is\ninvestigating whether certain GoDaddy officers and directors may have breached\nfiduciary duties owed to the Company or otherwise failed to adequately oversee\nGoDaddy’s business strategy, public disclosures, financial reporting, and\nrisk-management processes.\n\nAmong other things, the investigation concerns whether: Company leadership\nadequately disclosed the nature and impact of GoDaddy’s promotional\ndiscounting strategy; the Board and senior management maintained appropriate\noversight over material changes to GoDaddy’s go-to-market strategy;\nGoDaddy’s disclosure controls were sufficient to ensure that investors\nreceived accurate and complete information concerning bookings trends and\ncustomer-acquisition practices; certain officers or directors permitted or\ncaused the Company to make materially misleading public statements; and the\nCompany has suffered or may suffer harm through securities litigation, related\nlegal expenses, reputational damage, or other corporate losses.\n\nWhat Can You Do Now? If you are a current GoDaddy Inc. (NYSE: GDDY)\nshareholder and have held shares since before September 3, 2025, you can seek\ncorporate reforms, the return of funds back to the company, and a court\napproved incentive award at no cost to you whatsoever. Visit\nhttps://grabarlaw.com/the-latest/godaddy-shareholder-investigation/, contact\nJoshua H. Grabar at jgrabar@grabarlaw.com, or call 267-507-6085 to learn more.\n$GDDY #GDDY #Godaddy\n\nThe Simply Good Foods Company (NASDAQ: SMPL):\n\nGrabar Law Office is investigating claims on behalf of shareholders of The\nSimply Good Foods Company (NASDAQ: SMPL).\n\nWhat is This Investigation About? The investigation concerns whether certain\nofficers and directors breached the fiduciary duties they owed to the company.\n\nIf you purchased The Simply Good Foods Company (NASDAQ: SMPL) shares before\nFebruary 24, 2024, and still hold shares today, you can seek corporate\nreforms, the return of funds back to the company, and a court approved\nincentive award at no cost to you whatsoever. You are encouraged to visit\nhttps://grabarlaw.com/the-latest/smpl-shareholder-investigation/, contact\nJoshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085 to learn more.\n\nWhat is Alleged? As alleged in a recently filed securities fraud class action\nComplaint, The Simply Good Foods Company (NASDAQ: SMPL), through certain of\nits officers, made materially false and misleading statements and/or failed to\ndisclose materially adverse facts pertaining to the Company’s business,\noperations, and prospects. Specifically, Defendants failed to disclose to\ninvestors that: (1) that Simply Good Foods had lost key managerial personnel\nfollowing the acquisition of OWYN necessary for the successful integration of\nthe acquired OWYN assets; (2) that Simply Good Foods had materially increased\nits general and administrative spending to compensate for the loss of key\nmanagerial personnel; (3) the addition of a new pea protein supplier for OWYN\nprior to the acquisition had created significant product quality issues which\nhad negatively impacted the product; (4) Simply Good Foods had engaged in\npromotional activities for OWYN products above its historical practices,\neroding margins; (5) that, in order to stem the margin erosion, Simply Good\nFoods had cut brand support and marketing, further depressing product sales;\n(6) as a result of the above, the OWYN acquisition had largely failed to\nachieve its key strategic goals, the integration of OWYN had run into severe\noperational and execution problems, and the business and operational results\nfor the OWYN segment had been materially negatively impacted, undermining the\nacquisitions economic rationale; and (7) that, as a result of the foregoing,\nDefendants’ positive statements about the Company’s business, operations,\nand prospects were materially misleading and/or lacked a reasonable basis.\n\nWhat Can You Do Now? If you purchased The Simply Good Foods Company (NASDAQ:\nSMPL) shares before February 24, 2024, and still hold shares today, please\nvisit https://grabarlaw.com/the-latest/smpl-shareholder-investigation/,\ncontact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can\nseek corporate reforms, the return of funds back to the company, and a court\napproved incentive award at no cost to you whatsoever. #SMPL #SimplyGoodFoods\n$SMPL\n\nAttorney Advertising Disclaimer\n(https://www.globenewswire.com/Tracker?data=qMAsZfI9_PXGtQ40PFkFQf3yEZ7vPxepb63KbXHI9fzdhIQ1GfOquWkQhoYnreLExEaiVwxANz2aMqbfT_vJsCwF0CRc07Im2YFj71Z9sLY753_Zsc16RWEGu8bPdJIX2n6jGU7WLqU9fdMDZv2fD4aQ6ytPgMSrJPHJB7a7nzQ=)\n\nContact:\nJoshua H. Grabar, Esq.\nGrabar Law Office\nOne Liberty Place\n1650 Market Street, Suite 3600\nPhiladelphia, PA 19103\nTel:  267-507-6085\nEmail: jgrabar@grabarlaw.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/6c801a52-ae63-4c0d-a62c-5713903ad05d)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-08-31T12:44:25.196667491Z","server_sent_at_ms":1788180265196},"received_at":"2026-08-31T12:44:25.377Z","source_url":null},"analysis":{"id":"120117","press_release_id":"131212","analysis_json":{"industry":{"label":"Biotechnology","sector":"Health Care"},"redFlags":[],"eventType":"legal_litigation","narrative":"Grabar Law Office issued a shareholder-solicitation notice naming Aardvark Therapeutics, Flotek Industries, GoDaddy Inc., and The Simply Good Foods Company; no new disclosure from the companies themselves.\n\nThe release is a routine lead-plaintiff-deadline reminder soliciting investors to contact the firm on a contingency basis regarding class actions.\n\nThis is law-firm marketing, not an issuer disclosure or a court action; treat as low-signal noise.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm solicitation -- suppress."},"keyFigures":{},"quotedText":"","namedEntities":{"people":[{"name":"Joshua Grabar","role":"Attorney"}],"products":["ARD-101","OWYN"],"companies":[{"name":"Aardvark Therapeutics, Inc.","ticker":"AARD","relationship":"target"},{"name":"Flotek Industries, Inc.","ticker":"FTK","relationship":"target"},{"name":"GoDaddy Inc.","ticker":"GDDY","relationship":"target"},{"name":"The Simply Good Foods Company","ticker":"SMPL","relationship":"target"},{"name":"Grabar Law Office","relationship":"plaintiff law firm"}],"dollarAmounts":[{"amount":"$87.6 million","context":"Aardvark net proceeds from IPO"},{"amount":"$16.00","context":"Aardvark IPO price per share"},{"amount":"$400 million","context":"Flotek expected revenue backlog for PREPA project"}]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm shareholder solicitation issued by Grabar Law Office. No new disclosure from the issuer; no certified class, no settlement. Boilerplate lead-plaintiff-deadline reminder."},"tickerRelevance":{"others":[{"ticker":"FTK","relevance":"mentioned"},{"ticker":"GDDY","relevance":"mentioned"},{"ticker":"SMPL","relevance":"mentioned"}],"primary":"AARD"},"globalImportance":15,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"eventGravity":"law-firm-solicitation","issuerAuthored":false}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Grabar Law Office issued a shareholder-solicitation notice naming Aardvark Therapeutics, Flotek Industries, GoDaddy Inc., and The Simply Good Foods Company; no new disclosure from the companies themselves.\n\nThe release is a routine lead-plaintiff-deadline reminder soliciting investors to contact the firm on a contingency basis regarding class actions.\n\nThis is law-firm marketing, not an issuer disclosure or a court action; treat as low-signal noise.","key_figures":{},"named_entities":{"people":[{"name":"Joshua Grabar","role":"Attorney"}],"products":["ARD-101","OWYN"],"companies":[{"name":"Aardvark Therapeutics, Inc.","ticker":"AARD","relationship":"target"},{"name":"Flotek Industries, Inc.","ticker":"FTK","relationship":"target"},{"name":"GoDaddy Inc.","ticker":"GDDY","relationship":"target"},{"name":"The Simply Good Foods Company","ticker":"SMPL","relationship":"target"},{"name":"Grabar Law Office","relationship":"plaintiff law firm"}],"dollarAmounts":[{"amount":"$87.6 million","context":"Aardvark net proceeds from IPO"},{"amount":"$16.00","context":"Aardvark IPO price per share"},{"amount":"$400 million","context":"Flotek expected revenue backlog for PREPA project"}]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-08-31T13:43:53.277Z","global_importance":15,"audience_relevance":10,"importance_components":{"eventGravity":"law-firm-solicitation","issuerAuthored":false}},"durationMs":57807,"modelName":"glm-4.7"}}